−1.31USD
−37.94 MUSD
15.66 M
About Candel Therapeutics, Inc.
Sector
Industry
CEO
Paul-Peter Tak
Website
Headquarters
Needham
Employees (FY)
42
Founded
2002
FIGI
BBG00N0D4Z71
Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CADL is 5.54 USD — it has increased by 7.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Candel Therapeutics, Inc. stocks are traded under the ticker CADL.
Candel Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CADL stock is 11.37% volatile and has beta coefficient of −2.47. Check out the list of the most volatile stocks — is Candel Therapeutics, Inc. there?
CADL earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.19 USD resulting in a −52.63% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about Candel Therapeutics, Inc. earnings.
Candel Therapeutics, Inc. revenue for the last quarter amounts to 31.00 K USD despite the estimated figure of 15.50 K USD. In the next quarter revenue is expected to reach 13.00 K USD.
Yes, you can track Candel Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CADL stock has fallen by 14.77% compared to the previous week, the month change is a 271.81% rise, over the last year Candel Therapeutics, Inc. has showed a 305.12% increase.
CADL net income for the last quarter is −11.10 M USD, while the quarter before that showed −8.44 M USD of net income which accounts for −31.54% change. Track more Candel Therapeutics, Inc. financial stats to get the full picture.
Today Candel Therapeutics, Inc. has the market capitalization of 162.59 M, it has decreased by 20.31% over the last week.
No, CADL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CADL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Candel Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 42.00 employees. See our rating of the largest employees — is Candel Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Candel Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Candel Therapeutics, Inc. stock shows the strong buy signal. See more of Candel Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.